States / New York / A 44

A 44 In Committee

Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).

Chamber
House
Introduced
Jan 8, 2025
Last action
Jan 7, 2026 — REFERRED TO HEALTH
Session
2025-2026
Momentum
35 · Low